Ms. Stephanie W Rodrigue, L.P.C. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 118 Broadway Ave, Schriever, LA 70395 Phone: 985-859-5956 Fax: 985-307-0190 |
Mrs. Shawn Bourgeois Gautreaux, LPC-S Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 106 Wauban Ave, Schriever, LA 70395 Phone: 985-492-0378 |
Miss Euneka Treniece Walker Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 166 Crestview Ct, Schriever, LA 70395 Phone: 985-791-4745 |
Mrs. Monique Albarado Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 600 Bull Run Rd, Schriever, LA 70395 Phone: 985-872-5529 Fax: 985-857-8270 |
News Archive
Functionally deaf patients can gain normal hearing with a new implant that replaces the middle ear. The unique invention from the Chalmers University of Technology has been approved for a clinical study. The first operation was performed on a patient in December 2012.
Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer's dementia.
Depression, known to be a condition with impaired psychosocial functioning that severely impacts the quality of life of patients and families, is actually defined with specific clinical symptoms such as sadness, difficulty to experience pleasure, sleep problems etc., present for at least two weeks. At least 40% of depressed patients actually benefit from an antidepressant treatment, whereas 20-30% of patients may suffer from chronic depression that negatively impacts their quality of life. In order to improve the efficiency of treatment and reduce the burden of depressive disorders, depression needs to be defined at the neurobiological level.
Endologix, Inc., developer of minimally invasive treatments for aortic disorders, announced today that it has completed the acquisition of Nellix, Inc. Nellix has developed a revolutionary new device for the treatment of Abdominal Aortic Aneurysms (AAAs) that is expected to address the limitations of existing endovascular aneurysm repair (EVAR) devices and expand the global AAA market. Endologix announced its agreement to acquire Nellix on October 27, 2010.
› Verified 3 days ago